Comparison 34. Exposure to any drug; comparison group: general population; any; follow‐up>10 years.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Endometrial cancer; subgroup by effect estimate	5	129209	Risk Ratio (Random, 95% CI)	2.52 [1.80, 3.53]
1.1 SIR	3	8148	Risk Ratio (Random, 95% CI)	2.17 [1.44, 3.26]
1.2 HR	1	15030	Risk Ratio (Random, 95% CI)	3.39 [1.28, 8.97]
1.3 RR	1	106031	Risk Ratio (Random, 95% CI)	3.52 [1.67, 7.41]